Synthesis, Biological Evaluation, and Molecular Docking Studies of 2 r ,3 t ,4 c ‐Configured C ‐Furanosidic LpxC Inhibitors
Archiv der Pharmazie · 2026-06 · 359 (6)
DOI: 10.1002/ardp.70270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 07.07.2026. Verfasst von André Behnk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry, Universität Hamburg, Hamburg, Germany. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Anti-Bacterial Agents, Amidohydrolases, Enzyme Inhibitors. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum für Infektionsforschung.
Abstract (Originalsprache)
In chiral pool syntheses starting from d ‐mannitol and d ‐galactose, a series of four 2 r ,3 t ,4 c ‐configured C ‐furanosides was accessed. The synthesized stereoisomeric hydroxamic acids were tested for antibacterial activity as well as inhibitory potency toward the bacterial deacetylase LpxC, a promising target for antibiotics selectively targeting Gram‐negative bacteria. The obtained biological data were compared with those of the previously synthesized 12 stereoisomers, and molecular docking as well as molecular dynamics studies were performed to rationalize the observed structure–activity relationships. Initial in vitro ADMET studies revealed excellent microsomal metabolic and plasma stability of the investigated C ‐furanosides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Organic Chemistry, Universität Hamburg, Hamburg, Germany.
- German Center for Infection Research (DZIF), partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
- Institute of Pharmacy, Martin-Luther-University of Halle-Wittenberg, Halle (Saale), Germany.
- Department of Chemical Biology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
- German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany.
- Research group Pharmacokinetics and Pharmacodynamics Unit, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
ORCID-Profile: Wolfgang Sippl, Ralph Holl
Förderung
- Deutsches Zentrum für Infektionsforschung
Zitieren
APA
Behnk, A., Lüttchens, F., Wichter, F., Hoff, K., Venanzi, E., Wimmer, S., Vorreiter, C., Rox, K., Sippl, W., & Holl, R. (2026). Synthesis, Biological Evaluation, and Molecular Docking Studies of 2 r ,3 t ,4 c ‐Configured C ‐Furanosidic LpxC Inhibitors. Archiv der Pharmazie, 359(6). https://doi.org/10.1002/ardp.70270
Vancouver
Behnk A, Lüttchens F, Wichter F, Hoff K, Venanzi E, Wimmer S, et al. Synthesis, Biological Evaluation, and Molecular Docking Studies of 2 r ,3 t ,4 c ‐Configured C ‐Furanosidic LpxC Inhibitors. Archiv der Pharmazie. 2026;359(6). doi:10.1002/ardp.70270
BibTeX
@article{Behnk2026,
author = {Behnk, André and Lüttchens, Fabian and Wichter, Frederick and Hoff, Katharina and Venanzi, Elisa and Wimmer, Stefan and Vorreiter, Christopher and Rox, Katharina and Sippl, Wolfgang and Holl, Ralph},
title = {Synthesis, Biological Evaluation, and Molecular Docking Studies of 2 r ,3 t ,4 c ‐Configured C ‐Furanosidic LpxC Inhibitors},
journal = {Archiv der Pharmazie},
year = {2026},
volume = {359},
number = {6},
doi = {10.1002/ardp.70270}
}
EUVIMED